Accelerated Brain Stimulation for Treatment-Resistant Depression
Part of Brain & nervous system, Mental health clinical trials.
This study tests an accelerated form of iTBS (a non-invasive brain stimulation technique) for depression that hasn't improved with antidepressant medications. The goal is to help people with major depression who haven't responded adequately to at least one antidepressant drug.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 18–65 years old
- Diagnosed with major depressive disorder and tried at least one antidepressant without adequate relief
- Currently on a stable dose of antidepressant medication for at least 4 weeks
- Moderate to severe depression symptoms (HAM-D score of 14 or higher)
- No history of bipolar disorder, schizophrenia, or other psychotic disorders
- No metal implants in head/neck, pacemakers, cochlear implants, or prior brain stimulation procedures
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an accelerated form of brain stimulation called iTBS to see if it can help people with both PTSD and depression. It may be a good option if you have not found enough relief from your current treatments.
This study is testing whether a new type of brain stimulation called intermittent theta burst stimulation (iTBS) can help people with treatment-resistant depression (depression that hasn't improved with standard medicines). It also looks at certain blood markers to see if they can predict how well someone will respond to this treatment.
This trial tests a new way of delivering a non-invasive brain stimulation treatment called iTBS for depression. The treatment is personalized based on brain scans, and the study aims to see if it can help reduce depressive symptoms.
This trial tests a new type of brain stimulation called theta-burst stimulation to see if it helps treat depression. It is for people aged 18-50 who are currently experiencing a major depressive episode and are on a stable antidepressant regimen.
This trial tests a new type of brain stimulation treatment for people with major depression that hasn't improved with standard treatments. The treatment uses magnetic pulses to target specific brain areas over about 2 weeks.
This trial tests a new form of brain stimulation called iTBS (a type of repetitive transcranial magnetic stimulation) that is personalized for each person, compared to a sham (inactive) treatment. It aims to see if this personalized approach can safely reduce symptoms of depression.
Hear when a new Major Depressive Disorder (MDD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.